U.S. PHYSICAL THERAPY INC (USPH) Stock Fundamental Analysis
USA - NYSE:USPH - US90337L1089 - Common Stock
78.48 USD
-1.67 (-2.08%)
78.481 USD
0 (0%)
Taking everything into account, USPH scores 5 out of 10 in our fundamental rating. USPH was compared to 101 industry peers in the Health Care Providers & Services industry. USPH has only an average score on both its financial health and profitability. USPH is valied quite expensively at the moment, while it does show a decent growth rate.
1. Profitability
1.1 Basic Checks
In the past year USPH was profitable.
In the past year USPH had a positive cash flow from operations.
In the past 5 years USPH has always been profitable.
USPH had a positive operating cash flow in each of the past 5 years.
1.2 Ratios
Looking at the Return On Assets, with a value of 2.93%, USPH is in the better half of the industry, outperforming 64.36% of the companies in the same industry.
Looking at the Return On Equity, with a value of 6.91%, USPH is in the better half of the industry, outperforming 66.34% of the companies in the same industry.
USPH has a Return On Invested Capital of 5.72%. This is in the better half of the industry: USPH outperforms 60.40% of its industry peers.
USPH had an Average Return On Invested Capital over the past 3 years of 5.78%. This is below the industry average of 9.19%.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 2.93% | ||
| ROE | 6.91% | ||
| ROIC | 5.72% |
ROA(3y)2.54%
ROA(5y)3.42%
ROE(3y)6.25%
ROE(5y)8.16%
ROIC(3y)5.78%
ROIC(5y)6.77%
1.3 Margins
USPH's Profit Margin of 4.74% is fine compared to the rest of the industry. USPH outperforms 76.24% of its industry peers.
USPH's Profit Margin has declined in the last couple of years.
Looking at the Operating Margin, with a value of 11.00%, USPH belongs to the top of the industry, outperforming 81.19% of the companies in the same industry.
In the last couple of years the Operating Margin of USPH has declined.
Looking at the Gross Margin, with a value of 18.96%, USPH is doing worse than 60.40% of the companies in the same industry.
USPH's Gross Margin has declined in the last couple of years.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 11% | ||
| PM (TTM) | 4.74% | ||
| GM | 18.96% |
OM growth 3Y-9.96%
OM growth 5Y-5.7%
PM growth 3Y-13.05%
PM growth 5Y-8.65%
GM growth 3Y-6.9%
GM growth 5Y-3.92%
2. Health
2.1 Basic Checks
The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so USPH is destroying value.
The number of shares outstanding for USPH has been increased compared to 1 year ago.
USPH has more shares outstanding than it did 5 years ago.
USPH has a better debt/assets ratio than last year.
2.2 Solvency
USPH has an Altman-Z score of 2.22. This is not the best score and indicates that USPH is in the grey zone with still only limited risk for bankruptcy at the moment.
USPH has a Altman-Z score (2.22) which is comparable to the rest of the industry.
USPH has a debt to FCF ratio of 2.63. This is a good value and a sign of high solvency as USPH would need 2.63 years to pay back of all of its debts.
USPH has a better Debt to FCF ratio (2.63) than 81.19% of its industry peers.
USPH has a Debt/Equity ratio of 0.30. This is a healthy value indicating a solid balance between debt and equity.
USPH's Debt to Equity ratio of 0.30 is fine compared to the rest of the industry. USPH outperforms 65.35% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.3 | ||
| Debt/FCF | 2.63 | ||
| Altman-Z | 2.22 |
ROIC/WACC0.67
WACC8.52%
2.3 Liquidity
A Current Ratio of 1.18 indicates that USPH should not have too much problems paying its short term obligations.
The Current ratio of USPH (1.18) is worse than 61.39% of its industry peers.
A Quick Ratio of 1.18 indicates that USPH should not have too much problems paying its short term obligations.
USPH has a Quick ratio (1.18) which is in line with its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.18 | ||
| Quick Ratio | 1.18 |
3. Growth
3.1 Past
USPH shows a small growth in Earnings Per Share. In the last year, the EPS has grown by 7.35%.
The Earnings Per Share has been decreasing by -1.76% on average over the past years.
Looking at the last year, USPH shows a quite strong growth in Revenue. The Revenue has grown by 16.24% in the last year.
Measured over the past years, USPH shows a small growth in Revenue. The Revenue has been growing by 6.85% on average per year.
EPS 1Y (TTM)7.35%
EPS 3Y-6.63%
EPS 5Y-1.76%
EPS Q2Q%10.96%
Revenue 1Y (TTM)16.24%
Revenue growth 3Y10.69%
Revenue growth 5Y6.85%
Sales Q2Q%18.04%
3.2 Future
Based on estimates for the next years, USPH will show a small growth in Earnings Per Share. The EPS will grow by 6.44% on average per year.
USPH is expected to show quite a strong growth in Revenue. In the coming years, the Revenue will grow by 9.97% yearly.
EPS Next Y3.98%
EPS Next 2Y9.52%
EPS Next 3Y6.44%
EPS Next 5YN/A
Revenue Next Year16.19%
Revenue Next 2Y11.04%
Revenue Next 3Y9.97%
Revenue Next 5YN/A
3.3 Evolution
When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
4. Valuation
4.1 Price/Earnings Ratio
USPH is valuated quite expensively with a Price/Earnings ratio of 29.84.
The rest of the industry has a similar Price/Earnings ratio as USPH.
The average S&P500 Price/Earnings ratio is at 27.38. USPH is around the same levels.
Based on the Price/Forward Earnings ratio of 25.36, the valuation of USPH can be described as expensive.
Compared to the rest of the industry, the Price/Forward Earnings ratio of USPH is on the same level as its industry peers.
When comparing the Price/Forward Earnings ratio of USPH to the average of the S&P500 Index (22.86), we can say USPH is valued inline with the index average.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 29.84 | ||
| Fwd PE | 25.36 |
4.2 Price Multiples
Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of USPH is on the same level as its industry peers.
Compared to the rest of the industry, the Price/Free Cash Flow ratio of USPH indicates a somewhat cheap valuation: USPH is cheaper than 62.38% of the companies listed in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 19.6 | ||
| EV/EBITDA | 13.14 |
4.3 Compensation for Growth
The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates an expensive valuation of the company.
PEG (NY)7.5
PEG (5Y)N/A
EPS Next 2Y9.52%
EPS Next 3Y6.44%
5. Dividend
5.1 Amount
USPH has a Yearly Dividend Yield of 2.19%. Purely for dividend investing, there may be better candidates out there.
Compared to an average industry Dividend Yield of 2.43, USPH pays a better dividend. On top of this USPH pays more dividend than 92.08% of the companies listed in the same industry.
Compared to an average S&P500 Dividend Yield of 2.38, USPH has a dividend comparable with the average S&P500 company.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 2.19% |
5.2 History
The dividend of USPH is nicely growing with an annual growth rate of 9.09%!
USPH has paid a dividend for at least 10 years, which is a reliable track record.
USPH has not decreased its dividend in the last 3 years.
Dividend Growth(5Y)9.09%
Div Incr Years4
Div Non Decr Years4
5.3 Sustainability
USPH pays out 77.94% of its income as dividend. This is not a sustainable payout ratio.
The dividend of USPH is growing, but the earnings are growing slower. This means the dividend growth is not sustainable.
DP77.94%
EPS Next 2Y9.52%
EPS Next 3Y6.44%
78.48
-1.67 (-2.08%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)
Earnings (Next)
Inst Owners102.22%
Inst Owner Change1.58%
Ins Owners1.9%
Ins Owner Change0.17%
Market Cap1.19B
Analysts84.62
Price Target108.32 (38.02%)
Short Float %4.39%
Short Ratio3.86
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 2.19% |
Yearly Dividend1.76
Dividend Growth(5Y)9.09%
DP77.94%
Div Incr Years4
Div Non Decr Years4
Ex-Date
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)10.25%
Min EPS beat(2)9.44%
Max EPS beat(2)11.07%
EPS beat(4)2
Avg EPS beat(4)2.96%
Min EPS beat(4)-7.64%
Max EPS beat(4)11.07%
EPS beat(8)3
Avg EPS beat(8)-1.31%
EPS beat(12)5
Avg EPS beat(12)-0.32%
EPS beat(16)8
Avg EPS beat(16)0%
Revenue beat(2)2
Avg Revenue beat(2)1.85%
Min Revenue beat(2)1.65%
Max Revenue beat(2)2.04%
Revenue beat(4)4
Avg Revenue beat(4)1.28%
Min Revenue beat(4)0.22%
Max Revenue beat(4)2.04%
Revenue beat(8)6
Avg Revenue beat(8)0.67%
Revenue beat(12)7
Avg Revenue beat(12)0.35%
Revenue beat(16)8
Avg Revenue beat(16)-0.06%
PT rev (1m)0.95%
PT rev (3m)0.95%
EPS NQ rev (1m)0.75%
EPS NQ rev (3m)3.08%
EPS NY rev (1m)3.46%
EPS NY rev (3m)2.6%
Revenue NQ rev (1m)0.44%
Revenue NQ rev (3m)1.64%
Revenue NY rev (1m)1.76%
Revenue NY rev (3m)1.76%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 29.84 | ||
| Fwd PE | 25.36 | ||
| P/S | 1.63 | ||
| P/FCF | 19.6 | ||
| P/OCF | 16.63 | ||
| P/B | 2.38 | ||
| P/tB | N/A | ||
| EV/EBITDA | 13.14 |
EPS(TTM)2.63
EY3.35%
EPS(NY)3.09
Fwd EY3.94%
FCF(TTM)4
FCFY5.1%
OCF(TTM)4.72
OCFY6.01%
SpS48
BVpS32.94
TBVpS-23.19
PEG (NY)7.5
PEG (5Y)N/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 2.93% | ||
| ROE | 6.91% | ||
| ROCE | 7.57% | ||
| ROIC | 5.72% | ||
| ROICexc | 5.91% | ||
| ROICexgc | 34.97% | ||
| OM | 11% | ||
| PM (TTM) | 4.74% | ||
| GM | 18.96% | ||
| FCFM | 8.34% |
ROA(3y)2.54%
ROA(5y)3.42%
ROE(3y)6.25%
ROE(5y)8.16%
ROIC(3y)5.78%
ROIC(5y)6.77%
ROICexc(3y)6.35%
ROICexc(5y)7.3%
ROICexgc(3y)37.05%
ROICexgc(5y)44.29%
ROCE(3y)7.65%
ROCE(5y)8.96%
ROICexcg growth 3Y-11.04%
ROICexcg growth 5Y-7.52%
ROICexc growth 3Y-14.51%
ROICexc growth 5Y-13.29%
OM growth 3Y-9.96%
OM growth 5Y-5.7%
PM growth 3Y-13.05%
PM growth 5Y-8.65%
GM growth 3Y-6.9%
GM growth 5Y-3.92%
F-Score6
Asset Turnover0.62
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.3 | ||
| Debt/FCF | 2.63 | ||
| Debt/EBITDA | 1.49 | ||
| Cap/Depr | 49.29% | ||
| Cap/Sales | 1.49% | ||
| Interest Coverage | 9.81 | ||
| Cash Conversion | 70.13% | ||
| Profit Quality | 176.01% | ||
| Current Ratio | 1.18 | ||
| Quick Ratio | 1.18 | ||
| Altman-Z | 2.22 |
F-Score6
WACC8.52%
ROIC/WACC0.67
Cap/Depr(3y)54.79%
Cap/Depr(5y)61.53%
Cap/Sales(3y)1.47%
Cap/Sales(5y)1.57%
Profit Quality(3y)269.82%
Profit Quality(5y)263.85%
High Growth Momentum
Growth
EPS 1Y (TTM)7.35%
EPS 3Y-6.63%
EPS 5Y-1.76%
EPS Q2Q%10.96%
EPS Next Y3.98%
EPS Next 2Y9.52%
EPS Next 3Y6.44%
EPS Next 5YN/A
Revenue 1Y (TTM)16.24%
Revenue growth 3Y10.69%
Revenue growth 5Y6.85%
Sales Q2Q%18.04%
Revenue Next Year16.19%
Revenue Next 2Y11.04%
Revenue Next 3Y9.97%
Revenue Next 5YN/A
EBIT growth 1Y19.82%
EBIT growth 3Y-0.34%
EBIT growth 5Y0.76%
EBIT Next Year34.6%
EBIT Next 3Y17.41%
EBIT Next 5YN/A
FCF growth 1Y-1.2%
FCF growth 3Y-1.21%
FCF growth 5Y4.7%
OCF growth 1Y2.73%
OCF growth 3Y-0.65%
OCF growth 5Y3.71%